Padagis
CompanyUnited States
Padagis develops 2 assets, the furthest approved (estradiol in atrophic vaginitis). Mostly small molecule acting on ESR2, inflammation and ESR1; based in the United States.
- 2
- Assets
- Furthest
- Approved
- 1
- Trial
- 0
- Signals
Pipeline
2Estrogen receptor agonist for hormone replacement
Approved, Small molecule, ESR2, Inflammation, atrophic vaginitis, hypogonadism
Estrogen receptor agonist for hormone replacement
Approved, Small molecule, ESR2, Inflammation, atrophic vaginitis, hypogonadism
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms5
- Trials1
- Similar companies6
Updated 9 Oct 2026 · 120 sources